Brief: IPCA Laboratories Says EIR Classifies Co's Manufacturing Facility At Indore, Pithampur As Voluntary Action Indicated
31/10/2023 03:23
Oct 31 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* CLASSIFICATION OF USFDA INSPECTION FOR MANUFACTURING
FACILITY AT
SEZ INDORE, PITHAMPUR
* MANUFACTURING FACILITY AT SEZ INDORE, PITHAMPUR RECEIVED
ESTABLISHMENT INSPECTION REPORT
* ESTABLISHMENT INSPECTION REPORT CLASSIFYING MANUFACTURING
FACILITY AS VOLUNTARY ACTION INDICATED (VAI)
* FACILITY CONSIDERED TO BE IN MINIMALLY ACCEPTABLE STATE OF
COMPLIANCE WITH REGARD TO CGMP
Source text for Eikon: ID:nBSE6scx4v
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees